Quantum BioPharma announced its participation in the 3rd Annual ArcStone-Kingswood Growth Summit in Toronto on September 16, 2026. Anthony Durkacz, the company's Co-founder and Executive Co-chairman, will present recent milestones and future growth plans. The event gathers investors and industry professionals for networking and presentations, offering Quantum a platform to attract potential investors and highlight its innovative biotech developments, including treatments for neurodegenerative and metabolic disorders. This participation could enhance Quantum's visibility and funding opportunities as it advances its drug candidates.
Quantum BioPharma's participation in the ArcStone-Kingswood Growth Summit 2026 provides context for readers interested in biotech developments. For readers following the health sector, here is Pluang's market snapshot as of Sep 15, 2026 18:13 WIB: out of 91 priced US health-sector stocks, 31 rose and 54 fell. Notable movers include ResMed Inc. (RMD) at USD 226.48 with a 1-day change of +1.57%, American Well Corp (AMWL) at USD 13.66 down 1.51%, and Heron Therapeutics Inc (HRTX) at USD 0.32 up 1.49%.
Mid-America Apartment Communities, Inc. (MAA), a major apartment REIT focused on the U.S. Sunbelt region, faces mixed analyst opinions as it prepares for the BofA Securities 2026 Global Real Estate Conference on September 16. Analysts have recently a...
UBS lowered its price target for Comcast from $32 to $27, citing expected higher broadband subscriber losses, weaker theme-park results, and lower revenue and EBITDA in the near term. Comcast is also undergoing a major restructuring to spin off NBCUn...
Hooker Furniture Corporation reported Q3 2026 revenue of $63.3 million and operating income of $1.3 million, beating consensus on profitability despite slightly missing revenue estimates. The company’s gross margin expanded significantly to 31.8%, la...
Backblaze received a Buy rating with a $16 price target due to strong growth in its B2 Cloud Storage segment, which saw 34% revenue growth in Q2. Core growth excluding price increases was about 26%, and new large AI contracts such as CoreWeave improv...
Robinhood and Webull shares fell about 4% as the U.S. Senate prepared to vote on the CLARITY Act, a bill aimed at establishing clearer regulations for cryptocurrency markets. The vote's outcome is uncertain, causing investor anxiety since both broker...
